Preclinical
Filter News
Found 9,600 articles
-
Telik, Inc. Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2
10/26/2007
-
Hana Biosciences, Inc. Presents Positive Preclinical Data for Three Anti-Cancer Product Candidates At the AACR-NCI-EORTC International Conference
10/26/2007
-
Immunomedics, Inc. Develops Two New Drug Immunoconjugates For Targeted Therapy of Colon and Lung Cancers
10/26/2007
-
Cell Therapeutics, Inc. Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development
10/26/2007
-
ArQule, Inc. Announces Clinical and Pre-Clinical Data on Anti-Metastatic Potential of ARQ 197, a Selective c-Met Inhibitor
10/25/2007
-
ImmunoGen, Inc. Reports New Clinical and Preclinical Data at AACR-NCI-EORTC
10/25/2007
-
ARIUS Research Inc. Announces New Findings in Trop-2 and CD59 CANCER Antibody Programs
10/25/2007
-
BiPar Sciences, Inc. Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor
10/25/2007
-
GlobeImmune, Inc. Announces Presentation of Pre-Clinical Data on GI-10001 for Chronic Myelogenous Leukemia (CML) at International Conference on Molecular Targets and Cancer Therapeutics
10/25/2007
-
Curis, Inc. Announces Presentation at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
10/25/2007
-
Synvista Therapeutics' Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
10/25/2007
-
SuperGen, Inc.'s Novel Hypomethylating Agent Highlighted at AACR Plenary Session
10/25/2007
-
Cell Therapeutics, Inc. Novel Alternative Approach to Inhibiting Insulin Growth Factor (IGF) May Provide New Treatment for Breast Cancer
10/25/2007
-
Synta Pharmaceuticals Presents New Data on Elesclomol (Formerly STA-4783) at AACR-NCI-EORTC International Conference
10/25/2007
-
Seattle Genetics, Inc. Reports Preclinical Data on SGN-40 and an Anti-CD19 Antibody-Drug Conjugate
10/25/2007
-
ZIOPHARM Oncology, Inc.: Clinical and Preclinical Data for Oral Indibulin (ZIO-301) Presented at AACR/NCI/EORTC Conference
10/25/2007
-
Avalon Pharmaceuticals Announces Beta-catenin Pathway Inhibitors Demonstrate Significant Tumor Growth Inhibition
10/25/2007
-
Data Show SuperGen, Inc.'s Multi-Targeted Tyrosine Kinase Inhibitor Demonstrates Synergy with DNA Damaging Agents
10/25/2007
-
EntreMed, Inc. Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model Results Consistent with MKC-1 Akt-mTOR Inhibitor Mechanism
10/25/2007
-
Intradigm Corporation Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice
10/25/2007